Skip to main content
Explore URMC

menu

VX15/2503 Treatment for Huntington's Disease

Basic Study Information

Purpose:
The purpose of this study is to evaluate the safety, tolerability, PK, and efficacy of VX15/2503 in subjects with late prodromal and early manifest Huntington's disease.

Location: University of Rochester

Study Contact Information

Study Coordinator: Richard Barbano, MD, PhD
Phone: 1-800-487-7671
Email: info@hsglimited.org

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search